XML 37 R28.htm IDEA: XBRL DOCUMENT
v3.23.2

Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2023
Segment Reporting [Abstract] |
Schedule of Segment Information | The following table summarizes the segment information (in thousands):
|  | Three Months Ended June 30, |  | Six Months Ended June 30,
|  | 2023 |  | 2022 |  | 2023 |  | 2022
Net revenues: |  |  |  |  |  |  |  |
Clinical Services |  | $ | 123,156 |  |  | $ | 105,635 |  |  | $ | 238,025 |  |  | $ | 204,426 |
Advanced Diagnostics |  | 23,761 |  |  | 19,437 |  |  | 46,112 |  |  | 37,815 |
Total revenue |  | 146,917 |  |  | 125,072 |  |  | 284,137 |  |  | 242,241 |
Cost of revenue: |  |  |  |  |  |  |  |
Clinical Services(1) |  | 71,746 |  |  | 67,035 |  |  | 139,038 |  |  | 132,302 |
Advanced Diagnostics(2) |  | 15,280 |  |  | 14,091 |  |  | 30,394 |  |  | 27,761 |
Total cost of revenue |  | 87,026 |  |  | 81,126 |  |  | 169,432 |  |  | 160,063 |
Gross Profit: |  |  |  |  |  |  |  |
Clinical Services |  | 51,410 |  |  | 38,600 |  |  | 98,987 |  |  | 72,124 |
Advanced Diagnostics |  | 8,481 |  |  | 5,346 |  |  | 15,718 |  |  | 10,054 |
Total gross profit |  | $ | 59,891 |  |  | $ | 43,946 |  |  | $ | 114,705 |  |  | $ | 82,178 |
(1) Clinical Services cost of revenue for both the three months ended June 30, 2023 and June 30, 2022 includes $4.3 million of amortization of acquired Inivata developed technology intangible assets. Clinical Services cost of revenue for both the six months ended June 30, 2023 and June 30, 2022 includes $8.5 million of amortization of acquired Inivata developed technology intangible assets. (2) Advanced Diagnostics cost of revenue for both the three months ended June 30, 2023 and June 30, 2022 includes $0.6 million of amortization of acquired Inivata developed technology intangible assets. Advanced Diagnostics cost of revenue for both the six months ended June 30, 2023 and June 30, 2022 includes $1.2 million of amortization of acquired Inivata developed technology intangible assets.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration